7Baggers
Quarterly
Annual
    Unit: USD2025-09-27 2025-06-28 2025-03-29 2024-12-28 2024-09-28 2024-06-29 2024-03-30 2023-12-30 2023-04-01 2022-03-26 2021-03-27 2020-03-28 2019-03-30 2018-03-31 2017-04-01 2016-03-26 2015-03-28 2014-03-29 2013-03-30 2012-03-31 2011-03-26 2010-03-27 2009-03-28 2008-03-29 2007-03-31 2006-04-01 2004-03-27 
      
    		                           
      operating activities
    		                           
      net income
    		19,364,000 41,893,000 29,806,000 46,193,000 50,033,000 52,624,000 47,096,000 57,987,000 78,195,000 124,839,000 77,240,000 40,895,000 63,300,000 57,473,000 32,383,000 29,184,000 30,015,000 27,638,000 26,780,000 26,847,000 20,557,000 16,957,000 13,894,000 23,743,000 21,604,000 24,350,000 8,102,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                           
      depreciation and amortization
    		11,509,000 12,149,000 12,226,000 12,737,000 15,371,000 14,488,000 14,142,000 13,655,000 15,198,000 13,757,000                  
      non-cash interest charges
    		66,000 66,000 66,000 65,000 66,000 66,000 66,000 65,000 66,000 112,000 112,000 63,000 63,000 63,000 64,000 54,000 55,000 54,000 55,000 54,000 55,000 55,000 55,000 43,000 43,000 44,000 68,000 
      provisions for losses on trade and other accounts receivable
    		3,393,000 3,457,000 6,455,000 5,208,000 4,218,000 4,986,000 3,854,000 3,523,000 3,199,000 2,626,000 547,000 4,122,000 2,150,000 2,735,000 1,857,000 1,494,000 702,000 729,000 829,000 923,000 1,226,000 1,027,000 2,743,000 1,045,000 392,000 1,892,000 1,626,000 
      gains on sales/disposals of operating property
    		-281,000 -559,000 -830,000 -393,000 -649,000 -307,000 -248,000 -728,000 -1,140,000 -165,000 -24,000 -858,000 -876,000 -852,000 -463,000 -874,000 -107,000 -59,000 -642,000         
      impairment of intangible and other assets
    		                           
      deferred income taxes
    		11,795,000 -6,050,000 146,000 -2,631,000 -6,111,000 3,011,000 -1,259,000 -2,114,000 758,000 1,324,000 -1,110,000 797,000 2,079,000 -757,000 -709,000 2,682,000 885,000 -2,088,000 1,263,000 5,131,000 -1,068,000 -805,000 783,000 1,684,000 654,000 276,000 42,000 
      stock-based compensation
    		1,586,000 1,619,000 2,038,000 -138,000 -43,000 1,892,000 1,724,000 12,000 1,852,000 1,995,000 4,029,000 631,000 1,938,000 3,710,000 994,000 1,100,000 1,667,000 1,164,000 1,618,000 1,525,000 1,205,000 1,185,000 1,389,000 1,693,000 1,792,000 1,411,000  
      changes in operating assets and liabilities:
    		                           
      increase in trade and other accounts receivable
    		10,217,000 -17,873,000 -27,068,000       -93,542,000          -17,509,000 -45,364,000      -9,344,000 
      increase in other assets
    		-911,000   -8,210,000 9,985,000   10,571,000       -174,000             
      increase in accounts payable
    		904,000 12,257,000 5,967,000  -4,828,000   -68,740,000 -37,068,000 22,207,000 33,935,000 179,000     -23,862,000 13,289,000 -9,967,000 2,544,000 23,407,000 12,475,000     11,229,000 
      increase in other liabilities
    		196,000 -1,611,000 8,514,000    10,497,000  2,640,000 11,910,000 13,008,000 4,404,000  -191,000 13,357,000 1,724,000 -9,580,000 8,108,000 3,261,000 -3,046,000 1,283,000 7,490,000 -5,149,000 1,040,000   -2,979,000 
      increase in insurance claims
    		1,391,000 -3,009,000 9,721,000 122,000 692,000   -1,547,000 -1,066,000 7,371,000 -109,562,000 6,122,000 -559,000 739,000 3,702,000 2,285,000 1,321,000 1,251,000 879,000 -6,542,000 2,971,000 -3,182,000 410,000 -1,631,000 9,043,000 -1,560,000 6,195,000 
      net cash from operating activities
    		89,333,000 7,138,000 55,698,000 61,122,000 83,096,000 48,135,000 94,208,000 89,863,000 139,035,000 94,965,000 69,891,000 99,216,000 121,416,000 72,002,000 61,948,000 72,038,000 49,270,000  52,834,000 19,912,000 16,604,000 24,109,000 80,993,000 34,266,000 52,079,000 97,538,000 21,991,000 
      investing activities
    		                           
      sales and maturities of investments
    		35,938,000 37,897,000 46,858,000 30,993,000 21,281,000 39,868,000 19,923,000 19,229,000 40,349,000 12,420,000 7,957,000 7,963,000 25,739,000 12,698,000 23,155,000 10,636,000 10,651,000 14,558,000 12,702,000 8,912,000 23,870,000 6,082,000 442,000 4,037,000 12,232,000   
      purchases of investments
    		-32,259,000 -38,753,000 -48,085,000 -27,015,000 -17,376,000 -41,052,000 -15,869,000 -15,524,000 -31,425,000 -13,428,000 -8,716,000 -8,830,000 -26,707,000 -13,399,000 -23,678,000 -11,190,000 -11,107,000 -15,058,000 -23,152,000 -26,214,000 -20,650,000 -6,275,000 -8,828,000 -1,318,000 -15,505,000   
      purchases of operating property
    		-3,290,000 -2,481,000 -1,902,000 -6,742,000 -7,478,000 -7,497,000 -9,281,000 -10,294,000 -6,233,000 -3,609,000 -4,076,000 -5,799,000 -4,576,000 -3,814,000 -4,978,000 -828,000 -2,450,000 -732,000 -1,722,000 -1,026,000 -1,808,000 -22,239,000 -555,000 -361,000 -2,327,000 -668,000 -2,273,000 
      proceeds from sales of operating property
    		708,000 1,414,000 4,276,000 3,481,000 2,834,000 1,846,000 1,585,000 1,663,000 1,645,000 643,000 500,000 2,081,000 2,130,000 2,285,000 1,665,000 2,273,000 656,000 276,000 1,943,000 1,073,000 300,000 55,000 28,000  2,165,000 415,000 352,000 
      net cash provided (used) by investing activities
    		  1,147,000      4,336,000       891,000    -17,255,000 1,712,000      -342,000 
      financing activities
    		                           
      decrease in cash overdraft
    		-10,149,000 -1,218,000 -1,674,000 10,287,000 -7,612,000 6,684,000 -9,867,000  -26,758,000   -17,876,000 -13,820,000 -5,922,000 -6,878,000 -5,536,000 -6,219,000 -6,601,000 -6,262,000 -3,154,000 -1,470,000 -5,628,000   -275,000   
      dividends paid
    		-13,861,000 -13,916,000 -83,320,000 -12,718,000 -12,746,000 -11,777,000 -83,235,000 -11,828,000 -82,660,000 -84,711,000 -84,837,000 -86,283,000 -6,629,000 -69,293,000 -3,770,000 -3,396,000 -47,906,000 -18,641,000  -2,574,000 -2,394,000 -2,262,000 -2,068,000 -1,972,000 -1,682,000 -1,474,000  
      taxes paid in lieu of shares issued related to stock-based compensation plans
    		-17,000 -7,000 -909,000 0 -668,000 -200,000 -3,060,000 1,000 -8,236,000 -10,183,000 -1,241,000 -2,994,000 -7,923,000 -2,704,000 -339,000 -1,527,000 -2,069,000 -1,650,000 -1,633,000         
      purchases of common stock
    		-40,930,000 -41,939,000 -60,361,000 -2,703,000 -22,182,000   -38,486,000 -15,433,000 -109,332,000  -115,962,000 -12,977,000 -1,508,000  -10,228,000 -31,300,000 -37,052,000    -4,507,000 -11,958,000  -23,585,000 -11,131,000 -16,407,000 
      principal payments on finance lease obligations
    		-8,293,000 -8,544,000 -8,339,000 -8,155,000 -7,965,000 -7,668,000 -7,239,000 -8,336,000 -9,408,000 -9,532,000 -9,778,000 -10,923,000 -11,995,000               
      net cash used by financing activities
    		-73,250,000 -65,624,000 -154,603,000 -13,289,000 -51,173,000 -69,476,000 -103,401,000 -45,175,000 -142,467,000 -163,965,000 -95,773,000 -233,463,000 -53,625,000 -91,265,000 -21,678,000 -31,748,000 -95,797,000  -25,882,000 -30,147,000 -17,998,000 -3,821,000 -47,024,000 -12,177,000 -62,356,000 -77,357,000 -15,813,000 
      effect of exchange rate changes on cash and cash equivalents
    		-428,000 2,226,000 160,000 -2,362,000 -416,000 -1,433,000 -537,000 1,620,000 502,000 815,000 252,000 -3,590,000 512,000 -318,000 137,000 583,000 -280,000 -432,000 -225,000 204,000 206,000 100,000 -87,000     
      decrease in cash and cash equivalents, including cash and cash equivalents classified as assets held for sale
    		                           
      less: net change in cash and cash equivalents classified as assets held for sale
    		                           
      net change in cash and cash equivalents
    		                           
      cash and cash equivalents at beginning of period
    		0 0 515,018,000  0 0 481,043,000    249,354,000 319,515,000 199,736,000 242,416,000 178,897,000 114,520,000 163,944,000 180,302,000 74,284,000 80,900,000 44,706,000 85,719,000 98,904,000 60,750,000 91,491,000 29,398,000 42,640,000 
      cash and cash equivalents at end of period
    		15,954,000 -58,183,000 417,420,000  30,768,000 -29,609,000 467,671,000    219,389,000 177,224,000 264,625,000 220,605,000 215,468,000 156,284,000 114,887,000 114,166,000 90,782,000 53,614,000 45,230,000 82,493,000 130,378,000 80,980,000 77,780,000 49,401,000 48,476,000 
      net cash used by investing activities
    		   717,000    -4,926,000  -3,974,000 -4,335,000 -4,454,000 -3,414,000 -2,230,000   -2,250,000  -10,229,000   -23,614,000 -2,408,000 -1,859,000 -3,434,000 -178,000  
      decrease in cash and cash equivalents
    		 -58,183,000 -97,598,000        -29,965,000      -49,057,000           
      decrease in other assets
    		  8,657,000    11,574,000  8,625,000 2,531,000 6,175,000 9,987,000 2,229,000   9,783,000   1,287,000 3,458,000 5,870,000 5,977,000 7,278,000 10,750,000 9,689,000 2,738,000  
      decrease in trade and other accounts receivable
    		   9,957,000 16,212,000 -7,206,000 18,871,000    33,440,000 21,369,000 84,505,000 2,901,000 16,427,000 67,842,000         10,481,000 84,836,000  
      decrease in accounts payable
    		      -11,713,000      -40,953,000 -9,127,000 -15,424,000 -51,674,000       -17,845,000 -6,142,000 -1,909,000 -18,368,000  
      purchase of non-marketable securities
    		                           
      payment for debt issue costs
    		                           
      proceeds from exercises of stock options
    		       0 28,000 56,000 77,000 575,000 319,000 979,000 1,717,000 105,000 429,000 1,133,000 1,611,000 723,000 70,000 159,000 533,000 4,964,000 2,026,000 2,376,000 3,458,000 
      increase in cash, cash equivalents and restricted cash
    		       41,382,000 1,406,000                   
      cash, cash equivalents and restricted cash at beginning of period
    		       0 339,581,000 219,571,000                  
      cash, cash equivalents at end of period
    		                           
      decrease in other liabilities
    		    -1,850,000        -3,776,000            -3,348,000 -2,016,000  
      increase in cash and cash equivalents
    		    30,768,000 -29,609,000 -13,372,000     -142,291,000 64,889,000 -21,811,000 36,571,000 41,764,000  -66,136,000 16,498,000 -27,286,000 524,000 -3,226,000 31,474,000 20,230,000 -13,711,000 20,003,000 5,836,000 
      net cash (used) provided by investing activities
    		     -6,835,000 -3,642,000        -3,836,000             
      decrease in insurance claims
    		      -396,000                     
      decrease (increase) in trade and other accounts receivable
    		        67,776,000        29,939,000 -41,625,000 20,288,000   -22,882,000 71,948,000 -3,101,000    
      increase in cash overdraft
    		         -20,263,000 6,000            -8,230,000 1,442,000  -5,834,000 -1,185,000 
      payment of deferred consideration
    		                           
      cash, cash equivalents and restricted cash at end of period
    		        340,987,000 147,412,000                  
      borrowings on revolving credit facility
    		         70,000,000            15,000,000     1,000,000 
      net change in other short-term investments
    		                 -3,249,000    -1,237,000 6,505,000 -4,217,000 1,000 1,448,000 1,579,000 
      consideration paid for acquisition
    		                           
      decrease in cash, cash equivalents and restricted cash
    		         -72,159,000                  
      depreciation and amortization of operating property and intangible assets
    		          12,101,000 11,505,000 11,316,000 10,997,000     7,183,000 6,740,000 6,399,000 5,792,000      
      decrease (increase) in other assets
    		             4,311,000   11,216,000 -1,560,000          
      purchase of noncontrolling interest
    		            -600,000        -8,000,000       
      net changes in other short-term investments
    		           131,000                
      payment of contingent consideration
    		             -985,000              
      consideration paid for acquisitions
    		                           
      excess tax benefits from stock-based awards
    		               149,000 486,000           
      principal payments on capital lease obligations
    		             -11,832,000 -12,408,000 -11,315,000     -6,023,000       
      depreciation and amortization of operating property
    		              9,934,000 8,438,000 7,019,000 6,768,000     5,485,000 5,130,000 4,617,000 4,093,000 3,199,000 
      operating activities of continuing operations
    		                           
      adjustments to reconcile net income to net cash from operating activities of continuing operations:
    		                           
      discontinued operations
    		                           
      changes in operating assets and liabilities, net of discontinued operations:
    		                           
      net cash from operating activities of continuing operations
    		                 13,669,000          
      investing activities of continuing operations
    		                           
      proceeds from sale of discontinued operations
    		                           
      net cash (used) provided by investing activities of continuing operations
    		                           
      financing activities of continuing operations
    		                           
      principal payments on long-term debt and capital lease obligations
    		                -9,218,000 -12,862,000 -19,853,000 -26,006,000  -6,592,000 -25,540,000 -17,759,000 -39,348,000 -62,988,000 -2,679,000 
      net cash used by financing activities of continuing operations
    		                 -75,168,000          
      cash flows from discontinued operations:
    		                           
      operating activities of discontinued operations
    		                           
      investing activities of discontinued operations
    		                           
      financing activities of discontinued operations
    		                           
      net cash from discontinued operations
    		                           
      excess tax effect on stock option exercises
    		                 505,000 255,000         
      net cash used by investing activities of continuing operations
    		                 -4,205,000          
      net cash used by discontinued operations
    		                           
      net cash provided (used) by investing activities of continuing operations
    		                           
      dividends on common stock
    		                           
      excess (shortfall) tax effect on stock option exercises
    		                   864,000 -181,000       
      losses (gains) on sales/disposals of operating property
    		                   -213,000    12,000    
      capital contribution from noncontrolling interest
    		                           
      losses on sales/disposals of operating property
    		                    63,000 20,000 2,000     
      losses (gains) on sales and disposals of operating property
    		                           
      excess tax benefit on stock option exercises
    		                     9,000 239,000 1,148,000 508,000 1,694,000  
      capital contribution for noncontrolling interest
    		                           
      director compensation paid in common stock
    		                           
      proceeds from repayment of note receivable arising from exercise of stock options
    		                           
      adjustments to reconcile net income to net cash provided (used) by operating activities:
    		                           
      gains on sales and disposals of operating property
    		                         -158,000  
      net cash provided (used) by operating activities
    		                           
      proceeds from repayment of notes receivable arising from exercises of stock options
    		                           
      (gains) losses on sales of operating property
    		                           
      gains on sales of operating property
    		                        -979,000   
      (gains) losses on sales and disposals of operating property
    		                           
      sales and maturities of long-term investments
    		                         10,328,000  
      purchases of long-term investments
    		                         -11,701,000  
      tax benefit on stock option exercises
    		                           
      losses on sales and disposals of operating property
    		                          72,000 
      income tax benefit on stock option exercises
    		                          1,175,000 
      maturities of long-term investments
    		                           
      decrease in prepaid expenses and other assets
    		                          2,606,000 
      increase in prepaid expenses and other assets
    		                           
      see accompanying notes to consolidated financial statements.
    		                           
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.